New Technologies for Transient Molecular Complex Characterization (SBIR [R43/R44])

The summary for the New Technologies for Transient Molecular Complex Characterization (SBIR [R43/R44]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
New Technologies for Transient Molecular Complex Characterization (SBIR [R43/R44]): -Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop new technologies, tools, and/or processes for the study of transient molecular complexes. Depending on the complex, such studies should have the potential for characterizing normal function or disease dysfunction and the effects of potential therapeutic interventions. -Awards will be used to create new technologies, tools, and/or processes that will help to study transient molecular complexes that are an integral part of normal cell physiology or that play a role in disease processes. Structural (stoichiometry, localization, symmetry, and overall shape) and kinetic characterization of these short-lived complexes will provide insight leading to a better understanding of normal processes and a means to efficiently search for diagnostics or therapeutic interventions for disease conditions. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-08-111, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms.
Federal Grant Title: New Technologies for Transient Molecular Complex Characterization (SBIR [R43/R44])
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-08-110
Type of Funding: Grant
CFDA Numbers: 93.389
CFDA Descriptions: National Center for Research Resources
Current Application Deadline: No deadline provided
Original Application Deadline: May 07, 2011
Posted Date: Apr 07, 2008
Creation Date: Apr 07, 2008
Archive Date: Jan 27, 2009
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Limited Competition: Competitive Revision for Technology Development within Biomedical Tec...
Centers of Biomedical Research Excellence (COBRE) (P20)
Instrument Development for Biomedical Applications (R21)
Limited Competition: Institutional Development Award (IDeA) Program Infrastructure for Cli...
High-End Instrumentation Grant Program (S10)
NCRR Science Education Partnership Award (SEPA) [R25]
Planning Grants for Institutional Clinical and Translational Science Awards
Institutional Clinical and Translational Science Award
More Grants from the National Institutes of Health
The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...
Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com